Literature DB >> 33274715

Disruption of Nrxn1α within excitatory forebrain circuits drives value-based dysfunction.

Opeyemi O Alabi1,2, M Felicia Davatolhagh1,2, Mara Robinson1, Michael P Fortunato1, Luigim Vargas Cifuentes1,2, Joseph W Kable3, Marc Vincent Fuccillo1.   

Abstract

Goal-directed behaviors are essential for normal function and significantly impaired in neuropsychiatric disorders. Despite extensive associations between genetic mutations and these disorders, the molecular contributions to goal-directed dysfunction remain unclear. We examined mice with constitutive and brain region-specific mutations in Neurexin1α, a neuropsychiatric disease-associated synaptic molecule, in value-based choice paradigms. We found Neurexin1α knockouts exhibited reduced selection of beneficial outcomes and impaired avoidance of costlier options. Reinforcement modeling suggested that this was driven by deficits in updating and representation of value. Disruption of Neurexin1α within telencephalic excitatory projection neurons, but not thalamic neurons, recapitulated choice abnormalities of global Neurexin1α knockouts. Furthermore, this selective forebrain excitatory knockout of Neurexin1α perturbed value-modulated neural signals within striatum, a central node in feedback-based reinforcement learning. By relating deficits in value-based decision-making to region-specific Nrxn1α disruption and changes in value-modulated neural activity, we reveal potential neural substrates for the pathophysiology of neuropsychiatric disease-associated cognitive dysfunction.
© 2020, Alabi et al.

Entities:  

Keywords:  Neurexin; cortex; mouse; neuroscience; reinforcement; reward learning; striatum; value

Mesh:

Substances:

Year:  2020        PMID: 33274715      PMCID: PMC7759380          DOI: 10.7554/eLife.54838

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  87 in total

1.  Examining executive functioning in children with autism spectrum disorder, attention deficit hyperactivity disorder and typical development.

Authors:  Blythe A Corbett; Laura J Constantine; Robert Hendren; David Rocke; Sally Ozonoff
Journal:  Psychiatry Res       Date:  2009-03-12       Impact factor: 3.222

2.  Functionally dissociable influences on learning rate in a dynamic environment.

Authors:  Joseph T McGuire; Matthew R Nassar; Joshua I Gold; Joseph W Kable
Journal:  Neuron       Date:  2014-11-19       Impact factor: 17.173

3.  Single-Cell mRNA Profiling Reveals Cell-Type-Specific Expression of Neurexin Isoforms.

Authors:  Marc V Fuccillo; Csaba Földy; Özgün Gökce; Patrick E Rothwell; Gordon L Sun; Robert C Malenka; Thomas C Südhof
Journal:  Neuron       Date:  2015-07-15       Impact factor: 17.173

4.  Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action.

Authors:  M Geppert; M Khvotchev; V Krasnoperov; Y Goda; M Missler; R E Hammer; K Ichtchenko; A G Petrenko; T C Südhof
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

Review 5.  Autism spectrum disorders: from genes to neurobiology.

Authors:  A Jeremy Willsey; Matthew W State
Journal:  Curr Opin Neurobiol       Date:  2014-11-28       Impact factor: 6.627

6.  Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings.

Authors:  Gabriel S Dichter; Cara A Damiano; John A Allen
Journal:  J Neurodev Disord       Date:  2012-07-06       Impact factor: 4.025

7.  Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.

Authors:  Michael S L Ching; Yiping Shen; Wen-Hann Tan; Shafali S Jeste; Eric M Morrow; Xiaoli Chen; Nahit M Mukaddes; Seung-Yun Yoo; Ellen Hanson; Rachel Hundley; Christina Austin; Ronald E Becker; Gerard T Berry; Katherine Driscoll; Elizabeth C Engle; Sandra Friedman; James F Gusella; Fuki M Hisama; Mira B Irons; Tina Lafiosca; Elaine LeClair; David T Miller; Michael Neessen; Jonathan D Picker; Leonard Rappaport; Cynthia M Rooney; Dean P Sarco; Joan M Stoler; Christopher A Walsh; Robert R Wolff; Ting Zhang; Ramzi H Nasir; Bai-Lin Wu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

8.  Altered social behaviours in neurexin 1α knockout mice resemble core symptoms in neurodevelopmental disorders.

Authors:  Hannah Mary Grayton; Markus Missler; David Andrew Collier; Cathy Fernandes
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

9.  Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression.

Authors:  Chelsea Lowther; Marsha Speevak; Christine M Armour; Elaine S Goh; Gail E Graham; Chumei Li; Susan Zeesman; Malgorzata J M Nowaczyk; Lee-Anne Schultz; Antonella Morra; Rob Nicolson; Peter Bikangaga; Dawa Samdup; Mostafa Zaazou; Kerry Boyd; Jack H Jung; Victoria Siu; Manjulata Rajguru; Sharan Goobie; Mark A Tarnopolsky; Chitra Prasad; Paul T Dick; Asmaa S Hussain; Margreet Walinga; Renske G Reijenga; Matthew Gazzellone; Anath C Lionel; Christian R Marshall; Stephen W Scherer; Dimitri J Stavropoulos; Elizabeth McCready; Anne S Bassett
Journal:  Genet Med       Date:  2016-05-19       Impact factor: 8.822

10.  Differential coding of reward and movement information in the dorsomedial striatal direct and indirect pathways.

Authors:  Jung Hwan Shin; Dohoung Kim; Min Whan Jung
Journal:  Nat Commun       Date:  2018-01-26       Impact factor: 14.919

View more
  3 in total

1.  Neurexin1⍺ differentially regulates synaptic efficacy within striatal circuits.

Authors:  M Felicia Davatolhagh; Marc V Fuccillo
Journal:  Cell Rep       Date:  2021-02-23       Impact factor: 9.423

Review 2.  Spatial and Temporal Gene Function Studies in Rodents: Towards Gene-Based Therapies for Autism Spectrum Disorder.

Authors:  Iris W Riemersma; Robbert Havekes; Martien J H Kas
Journal:  Genes (Basel)       Date:  2021-12-23       Impact factor: 4.096

3.  Neurexin 1 variants as risk factors for suicide death.

Authors:  Nancy William; Carsten Reissner; Robert Sargent; Todd M Darlington; Emily DiBlasi; Qingqin S Li; Brooks Keeshin; William B Callor; Elliott Ferris; Leslie Jerominski; Ken R Smith; Erik D Christensen; Douglas M Gray; Nicola J Camp; Markus Missler; Megan E Williams; Hilary Coon
Journal:  Mol Psychiatry       Date:  2021-06-25       Impact factor: 15.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.